首页 | 本学科首页   官方微博 | 高级检索  
     

依达拉奉注射液治疗急性脑梗死对神经功能缺损和日常生活活动能力的影响
引用本文:熊兵,戴百良,刘玲荣,汪文平. 依达拉奉注射液治疗急性脑梗死对神经功能缺损和日常生活活动能力的影响[J]. 中国现代医生, 2014, 0(2): 57-59
作者姓名:熊兵  戴百良  刘玲荣  汪文平
作者单位:[1]湖北省洪湖市人民医院神经内科,湖北洪湖433200 [2]湖北省洪湖市人民医院院办,湖北洪湖433200
摘    要:目的探讨依达拉奉注射液治疗脑梗死的临床效果。方法随机将60例脑梗死患者分为两组,每组30例。对照组给予常规治疗,研究组在此基础上加用依达拉奉注射液治疗。比较两组的临床疗效。结果治疗后14 d、21 d研究组ESS得分显著高于对照组(P<0.05或P<0.01),治疗后14 d、21 d、3个月研究组ADL得分显著高于对照组(P<0.01)。治疗后7d、14d、21d,研究组的ESS增分率和ADL增分率临床疗效均显著优于对照组(P<0.01)。结论依达拉奉注射液治疗急性脑梗死能够显著改善患者神经功能缺损状况,提高患者日常生活活动能力。

关 键 词:依达拉奉  脑梗死  自由基清除剂

Effect of edaravone on neurologic impairment and ADL for acute cerebral infarction
XIONG Bing,DAI Bailiang,LIU Lingron,WANG Wenping. Effect of edaravone on neurologic impairment and ADL for acute cerebral infarction[J]. , 2014, 0(2): 57-59
Authors:XIONG Bing  DAI Bailiang  LIU Lingron  WANG Wenping
Affiliation:1.Department of Neurology, Honghu People's Hospital in Hubei Province, Honghu 433200, China ;2.Office of Honghu People's Hospital in Hubei Province, Honghu 435200, China)
Abstract:Objective To discuss effect of edaravone on neurologic impairment and ADL for acute cerebral infarction. Methods Selected 60 cases with acute cerebral infarction were divided into study group and control group. Control group received by normal treatment. Study group was treated by edaravone based on above treatment. Clinical efficacies of two groups were compared. Results ESS scores of study group were higher than control group at 14 d, 21d after treatment (P 〈 0.05 or P 〈 0.01 ). ADL scores of study group were higher than control group at 14 d, 21 d and 3 months after treatment (P 〈 0.01 ). Clinical efficacy of study group was higher than control group at 7 d, 14 d, 21 d and 3 months after treatment (P 〈 0.01). Conclusion Edaravone for acute cerebral infarction shows good clinical efficacy, and can improve neurologic impairment and ADL.
Keywords:Edaravone  Cerebral infarction  Free-radical scavenger
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号